Twitter: x.com/stockmarkettday
#Follow4Follow
Let’s go 🚀🚀🚀
- ROCE: 80%, outstanding capital efficiency.
- ROA: 21%, strong asset utilization.
- Net Cash Position: €3B, ensuring financial stability.
- Net profit margin: 35%
A strong business with a durable moat. This is an opportunity for every investor!
Buy.
- ROCE: 80%, outstanding capital efficiency.
- ROA: 21%, strong asset utilization.
- Net Cash Position: €3B, ensuring financial stability.
- Net profit margin: 35%
A strong business with a durable moat. This is an opportunity for every investor!
Buy.
#OXY has weak financials (declining revenue/margins), and tough competition from more innovative players. Inflation & high interest rates adds additional pressure, so strong returns seems unlikely.
Definitely not a buy!
#OXY has weak financials (declining revenue/margins), and tough competition from more innovative players. Inflation & high interest rates adds additional pressure, so strong returns seems unlikely.
Definitely not a buy!
Hold/Sell.
Hold/Sell.
Stromg Buy.
Stromg Buy.
Buy.
Buy.
EPS growth remains good (2025: +5.8%). At a 15.8% discount to its high, valuation appears tempting but further downside is expected.
Hold.
EPS growth remains good (2025: +5.8%). At a 15.8% discount to its high, valuation appears tempting but further downside is expected.
Hold.
- ROE: 34% vs. industry avg. 7.5%
- Net income growth: 14% (5 yrs)
- Low payout ratio: 5%, rising to 8%
With AR, VR & AI investments, Meta’s long-term outlook is solid, but slightly overvalued atm.
Hold.
- ROE: 34% vs. industry avg. 7.5%
- Net income growth: 14% (5 yrs)
- Low payout ratio: 5%, rising to 8%
With AR, VR & AI investments, Meta’s long-term outlook is solid, but slightly overvalued atm.
Hold.
Recommendation: Buy.
Recommendation: Buy.
- Now 30.8% below its 52-week high at $60.21.
- Earnings estimates up 117.2% (2024) & 34% (2025).
- 42.5% long-term growth vs. 24.1% industry avg.
Pullback could be a buying opportunity
- Now 30.8% below its 52-week high at $60.21.
- Earnings estimates up 117.2% (2024) & 34% (2025).
- 42.5% long-term growth vs. 24.1% industry avg.
Pullback could be a buying opportunity
CagriSema phase 3 data showed 20.4% placebo-adjusted weight loss, below the 25% target. Shares now trade near our fair value estimate of $86, implying a forward P/E of 26x.
Rare buying opportunity for a fantastic stock!
Buy.
CagriSema phase 3 data showed 20.4% placebo-adjusted weight loss, below the 25% target. Shares now trade near our fair value estimate of $86, implying a forward P/E of 26x.
Rare buying opportunity for a fantastic stock!
Buy.
Buy.
Buy.
Buy.
Buy.
- 19x P/FCF
- 30-40% future FCF growth
- Wide moat from massive network effects, scale, and brand
It’s one of the most obvious large-cap longs in the market. That said, Uber’s management is a disaster keep that in mind. Once robo taxis flop, the upside is massive
- 19x P/FCF
- 30-40% future FCF growth
- Wide moat from massive network effects, scale, and brand
It’s one of the most obvious large-cap longs in the market. That said, Uber’s management is a disaster keep that in mind. Once robo taxis flop, the upside is massive
- Record revenue: $8.5B (+15% YoY)
- Net income doubled to $1.34B ($0.99 per share)
- AI server revenue hit $1.5B
Morgan Stanley raised its price target to $28.
- Record revenue: $8.5B (+15% YoY)
- Net income doubled to $1.34B ($0.99 per share)
- AI server revenue hit $1.5B
Morgan Stanley raised its price target to $28.
Will this news help #INTL to improve its stock price?
#stockmarketnews
Will this news help #INTL to improve its stock price?
#stockmarketnews